Figure 2.
Cumulative fludarabine AUCT0−∞ <14 mg*h/L associates with worse outcome. (A-C) Kaplan Meier plots of LFS and the occurrence of CD19-positive relapse and B-cell recovery from the day of CAR T-cell infusion stratified by cumulative fludarabine AUCT0−∞ of 14 mg*h/L. Groups were compared using the log-rank test. P values < .05 were considered statistically significant.

Cumulative fludarabine AUCT0−∞ <14 mg*h/L associates with worse outcome. (A-C) Kaplan Meier plots of LFS and the occurrence of CD19-positive relapse and B-cell recovery from the day of CAR T-cell infusion stratified by cumulative fludarabine AUCT0−∞ of 14 mg*h/L. Groups were compared using the log-rank test. P values < .05 were considered statistically significant.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal